Bio-Rad Laboratories (BIO) Competitors $232.33 -16.84 (-6.76%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, community ranking, analyst recommendations, profitability, dividends, valuation and earnings. Do analysts recommend BIO or MTD? Bio-Rad Laboratories currently has a consensus price target of $395.20, indicating a potential upside of 69.32%. Mettler-Toledo International has a consensus price target of $1,380.50, indicating a potential upside of 36.12%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, equities analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Mettler-Toledo International 1 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.22 Do insiders and institutionals hold more shares of BIO or MTD? 65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 17.1% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is BIO or MTD more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Bio-Rad Laboratories' net margin of -71.86%. Bio-Rad Laboratories' return on equity of 3.90% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories-71.86% 3.90% 2.76% Mettler-Toledo International 22.29%-591.54%26.78% Does the MarketBeat Community favor BIO or MTD? Bio-Rad Laboratories and Mettler-Toledo International both received 372 outperform votes by MarketBeat users. However, 64.70% of users gave Bio-Rad Laboratories an outperform vote while only 56.62% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformBio-Rad LaboratoriesOutperform Votes37264.70% Underperform Votes20335.30% Mettler-Toledo InternationalOutperform Votes37256.62% Underperform Votes28543.38% Which has more risk & volatility, BIO or MTD? Bio-Rad Laboratories has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Which has preferable valuation and earnings, BIO or MTD? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.57B2.55-$1.84B-$65.04-3.59Mettler-Toledo International$3.87B5.46$863.14M$40.5325.02 Does the media prefer BIO or MTD? In the previous week, Mettler-Toledo International had 19 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 28 mentions for Mettler-Toledo International and 9 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.40 beat Mettler-Toledo International's score of 1.22 indicating that Bio-Rad Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Mettler-Toledo International 20 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive SummaryMettler-Toledo International beats Bio-Rad Laboratories on 10 of the 16 factors compared between the two stocks. Remove Ads Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$6.54B$3.95B$5.17B$17.99BDividend YieldN/A0.60%5.35%4.05%P/E Ratio-3.5926.1021.9630.41Price / Sales2.554.07353.0326.22Price / Cash26.9536.0338.1517.54Price / Book1.001.706.174.19Net Income-$1.84B-$83.57M$3.19B$1.02B7 Day Performance-0.63%5.68%-3.50%-5.09%1 Month Performance-6.42%-8.27%-2.31%-8.37%1 Year Performance-29.50%-39.76%3.66%-3.44% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.7629 of 5 stars$232.33-6.8%$395.20+70.1%-26.9%$6.51B$2.57B-3.578,200News CoveragePositive NewsMTDMettler-Toledo International4.1214 of 5 stars$1,033.42+1.1%$1,380.50+33.6%-20.6%$21.54B$3.87B25.5018,000Analyst UpgradePositive NewsGap DownHigh Trading VolumeWATWaters4.61 of 5 stars$325.12+0.1%$401.31+23.4%-2.6%$19.32B$2.96B30.368,200Analyst ForecastGap DownHigh Trading VolumeILMNIllumina4.6518 of 5 stars$73.45-1.0%$140.65+91.5%-42.9%$11.63B$4.37B-9.569,030Analyst ForecastPositive NewsGap DownHigh Trading VolumeTECHBio-Techne4.7506 of 5 stars$52.31+1.1%$81.25+55.3%-24.1%$8.27B$1.20B52.843,100Analyst ForecastNews CoverageGap DownHigh Trading VolumeCRLCharles River Laboratories International4.8251 of 5 stars$133.97-2.1%$189.77+41.7%-46.0%$6.85B$4.05B893.1121,800Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownBRKRBruker4.6218 of 5 stars$38.70+6.1%$68.00+75.7%-54.2%$5.87B$3.37B50.928,520Analyst ForecastAnalyst RevisionNews CoverageGap DownHigh Trading VolumePACBPacific Biosciences of California3.097 of 5 stars$1.32+7.3%$2.46+86.2%-59.8%$393.17M$154.01M-0.80730Analyst ForecastNews CoveragePositive NewsGap DownHBIOHarvard Bioscience3.6423 of 5 stars$0.38-4.9%$4.50+1,082.7%-90.1%$16.77M$94.14M-1.15490Analyst ForecastGap DownTMOThermo Fisher Scientific4.872 of 5 stars$437.800.0%$653.23+49.2%-23.2%$165.16B$42.88B26.49130,000Analyst ForecastNews CoveragePositive NewsHigh Trading VolumeAAgilent Technologies4.4673 of 5 stars$103.48+0.5%$150.83+45.8%-27.4%$29.50B$6.51B23.7917,900Analyst ForecastPositive NewsGap Down Remove Ads Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 4/10/2025 by MarketBeat.com Staff From Our Partners6 stocks could soar on DOGE AI news …Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s policies mean HUGE income for investorsThanks to a Trump win… Investors have a HUGE opportunity at new income. The floodgates for U.S. oil prod...The Oxford Club | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for May 7th. Because on that day, I believe we could see a $2 Trillion shock INTO the ma...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIO Stock Free BIO Stock Alerts